A B S T R A C a The turnover and the catabolic fate of the B apoprotein of very low density lipoprotein (VLDL-B) was studied in 15 normal and hyperlipidemic subjects using reinjected autologous VLDL labeled with radioiodine. The specific radioactivity-time curve ofthe B apoprotein in total VLDL (Sf 20-400) was multiexponential but conformed to a two-pool model during the first 48 h of catabolism. The flux was highest in several hypertriglyceridemic subjects. The mass of pool A exceeded the intravascular content of VLDL-B by 30% on average, indicating extravascular metabolism of VLDL. The two-pool model might reflect the input of several populations of particles or heterogeneity of catabolic processes or pools. The flux of B apoprotein was also measured in several subclasses of VLDL, in smailler intermediate density lipoproteins, and in low density lipoproteins (LDL). In three subjects the flux was similar in Sf 60-400 and in Sf 12-60 lipoproteins, suggesting that VLDL was catabolized at least to a particle in the density range Sf 12-60. Subsequent catabolism appeared to proceed by two pathways: in normotriglyceridemiic subjects, B apoprotein flux in the Sf 20-400 and in Sf 12-20 lipoproteins was similar, whereas in hypertriglyceridemic subjects flux through Sf 12-20 accounted for only part of the VLDL-B flux.
A B S T R A C a The turnover and the catabolic fate of the B apoprotein of very low density lipoprotein (VLDL-B) was studied in 15 normal and hyperlipidemic subjects using reinjected autologous VLDL labeled with radioiodine. The specific radioactivity-time curve ofthe B apoprotein in total VLDL (Sf 20-400) was multiexponential but conformed to a two-pool model during the first 48 h of catabolism. The flux was highest in several hypertriglyceridemic subjects. The mass of pool A exceeded the intravascular content of VLDL-B by 30% on average, indicating extravascular metabolism of VLDL. The two-pool model might reflect the input of several populations of particles or heterogeneity of catabolic processes or pools. The flux of B apoprotein was also measured in several subclasses of VLDL, in smailler intermediate density lipoproteins, and in low density lipoproteins (LDL) . In three subjects the flux was similar in Sf 60-400 and in Sf lipoproteins, suggesting that VLDL was catabolized at least to a particle in the density range Sf 12-60. Subsequent catabolism appeared to proceed by two pathways: in normotriglyceridemiic subjects, B apoprotein flux in the Sf and in Sf [12] [13] [14] [15] [16] [17] [18] [19] [20] lipoproteins was similar, whereas in hypertriglyceridemic subjects flux through accounted for only part of the VLDL-B flux.
The flux of low density' lipoprotein B apoprotein (LDL-B), which is believed to be derived from VLDL catabolism, was calculated f'rom the area between the specific activity time curves of' VLDL-B and LDL-B. In subjects with normal plasmla triglyceride concentration, LDL-B flux was froml 91% to 113% of that of VLDL-B; but in three hy'pertriglyceridemic subjects showing high rates of VLDL-B transport, LDL-B flux was only one-third that of VLDL-B. This suggests that
INTRODUCTION
The metabolisnm of plasnma lipids is closely linked to that of the apoproteinis. The influx of lipids from the liver or gut requires the secretioni of the B apoproteiin (1) . Newly synthesized triglyceride (2) , and in all probability cholesterol (3) , enter plasma within very low density lipoprotein (VLDL)1 particles that, in their nascenit form, may conitaini only the single B apoproteini (4) (5) (6) . Within the plasmiia, VLDL acquire additional proteins, the C apoproteins (7) that are related functionally to the catabolisml of VLDL. As the triglyceride is removed through the actioni of a lipolytic system that is regulated by the C apoproteins (8, 9) , additional changes take place 1)oth to the surface and the core constituents of the lipoproteini. These include the progressive removal of the C apoproteins and enrichment with esterified cholesterol that lead to the formation of smaller cholesterol-rich lipoproteins (10, 11) .
Low density lipoproteins (LDL) are believed to originate in this way. Recent studies in man by Eisenberg et al. (10) and by Sigurdssoni et al. (12) termediate density and size are formed (13) , most of which are removed from the circulation without prior conversion to LDL in the rat (14) . Excessive accumulation of a subelass of intermediate lipoproteinis may reflect the failure of VLDL catabolism to proceed beyond a specific point, and it has been postulated that Type 3 hvperlipoproteinemia, which is characterized by the acctmulation of a cholesterol-rich intermediate density lipoprotein, develops in this way (15) .
The present study has investigated the catabolism of VLDL, or more specifically, that of its B apoprotein, in patients with and without increased concentrations of VLDL. The kinetics of VLDL removal and the transfer of B apoprotein radioactivity into intermediate lipoproteins and LDL have provided estimates of VLDL turnover in subjects with different degrees of hyperlipoproteinemia and the extent of VLDL conversion to smaller lipoproteins. In several subjects, two subclasses of VLDL have been labeled with separate isotopes and injected together to define the probable nature of the intermediate or "remnant" lipoprotein. Finally, a comparison ofVLDL turnover and LDL turnover (calculated from the rate of labeling of LDL from radiolabeled VLDL) has suggested different pathways of VLDL catabolism that appear to bypass LDL.
MIETHODS

Materials
1251-Na and 1311-Na, carrier free for protein iodination, were obtained from the Radiochemical Centre, Amersham, England. Urea (Univar, Ajax Co, Australia) was deionized by passing through Rexyn 1-300 columns immediately before use in gel filtration or preparation of polyacrylamide gels. 1,1,3,3 tetramethvl urea (TNIU) from Sigma Chemical Co., St. Louis, NIo., was redistilled twice before use and stored in dark glass bottles under N2 at 40C. Subjects 15 subjects, 12 men and 3 women, were studied in the metabolic ward. Four were normolipidemic and the remainder were hyperlipidemic, as shown in Table I . Three suffered f'rom coronary heart disease and two showed abnormal glucose tolerance, though not glycosuria (3 and 12) . None was receivinlg medication. The presence of' hyperlipidemia in other members of the family was sought in 8 of the 11 hyperlipidemic subjects, though the number of first-degree relatives available for study varied between one and four. Some subjects were deliberately studied because of the known occurrence of hyperlipidemia in other members of the family. Familial hyperlipidemia was not established in only one of the eight subjects (subject 14, who had no children and only one surviving parent who had normal plasma lipid levels). In the others, the affected relatives most commonly, but not invariably, showed a similar lipoprotein phenotype.
The response to drug treatmiient is also shown in Table I . As shown in Table I , some of the patients were overweight, especially those who were hypertriglyceridemic.
Preparation of radioiodinated lipoproteitns
Lipoproteins were separated from 40-5( ml of plasma obtained after subjects had fasted overnight. EDTA was added to 1 mM final concentration. Chylomicrons (Sf > 400), if present, were removed by centrif'uging plasma at 20,000 g for 30 min.
VLDL (Sf 20-400) were isolated by ultracentrifugation (16) (19) , as described previously (20) . All labeled preparations contained less than one atom of iodine per mole of protein (13) . 89-95% of the 125I was attached to the protein, with most of the remainder in the lipid moiety and <1% remaining unbound. Both the B and C apoproteins of VLDL were labeled by this procedure; after separation of the insoluble and soluble apoprotein with TMU, as described by Kane For the next 2 days of the turnover studies, the fat intake was less than 25% of total calories. Before and during the study, the weight and plasma lipid levels of all subjects remained steady, the weight change not exceeding 0.4 kg in any suibject over 3 days. The variability in the lipid levels in whole plasma was conisiderably less than in the VLDL-B concentration. Potassium iodide (180 mg) was administered before, during, and after the study to inhibit thyroid uptake of 1251. The nature of the investigationis was explained, and informend consent was obtainied.
Approximately 3-5mg ofapoprotein and 20-70 ,uCi of autologous sterile 1251-labeled lipoprotein was injected into each subject in the morning after an overnight fast. Double-labeled experiments were performed in some subjects (see Results).
In these studies, 131I-labeled lipoprotein containing 10-20 ,uCi in 3-5 mg of apoprotein was injected at the same time as 1251-labeled lipoprotein. During the first 24 h, samples of blood (20 ml) were withdrawn at regular intervals through an indwelling cannula kept patent by infusing 0.9% NaCl solution and by venipuncture thereafter for 3-14 days, depending oi the study.
Determination of B apoproteitn specific radioactivity Lipoprotein separation. Plasma samples (10 ml) were cenltrifuged at 4°C in the 40 rotor of a Beckman L3-50 ultracenitrifuge (Beckman Instruments, Inc.). VLDL or VLDL subfractions were separated as described above. Lipoproteins of Sf [12] [13] [14] [15] [16] [17] [18] [19] [20] or Sf 12-60 were obtained by adjusting the density of the infranate to 1.019 g/ml after removal of the lower density VLDL fraction. LDL (Sf ()-12) was isolated at d 1.063 g/ml and high density lipoprotein at d 1.21 g/ml by sequential ultracentrifugation according to Havel et al. (16) . All lipoproteinis were washed once at the appropriate density and dialyzed against 0.15 M NaCl buffer, and ali(luots were removed to determine total radioactivity and protein concentrations of each fraction.
Separation of the B apoprotein from VLDL and LDL. Isolation of B apoprotein was achieved by one of two methods. In several studies we used the technique described by Kane (21) which depends on the insolubility of the B apoprotein in TMU. The procedure was modified to obtain a direct estimate of the B apoprotein specific radioactivity. This was achieved by washing the lipid-protein pellicle once with 4.2 MI TNIU and twice with H2O, followed bv extractioni with chloroformii, methaniol, and diethyl ether (see below). The insolulble B apoproteini precipitate wcas theni dried unider NN2 anid dissolved in 0.1 MI NaOH. Aliquots were removed for protein determinlation anid radioassav.
Another procedure for separatinig B from soluble apoproteins was developed for some of these studies (subjects 2 and 7-15) and did show some advantages over the gel filtration and TMU methods and has been described elsewhere (22) . The method depends on the insolubility of B apoproteini in a lowv ionic strength buffer (5 mMJ NH4HCO3). An ali(quiot of V7LDL or LDL (containing from 0.5 to 2.0 mg of apoprotein) was dialyzed against 5 mM NH4HCO3, pH 8.0, and lyophilized. The samples were delipidated, usinig a modification of the chloroform, methanol, diethyl ether svstem described by W7iidmueller et al. (5) . The protein precipitate was washed with methanol plus diethyl ether and then with diethyl ether alone, after which it was dried, 0.5 ml of 5 mNI NH4HCO3 added, and the sample mixed and left overnight at room temperature. After the insoluble protein was sedimented, the supernate was removed and the pellet was washed once in 0.5 ml mM NH4HCO3 and centrifuged. After drying, the protein was dissolved in 0.1 NI NaOH and assayed for radioactivity and protein content (18) . Purified B apoprotein gave practically identical standard curves as bovine serum albumin, which was subsequently used to standardize protein assays. Similar observations have been reported by Kane et al. (23) .
To validate the method described above, aliquots of some samples were also processed with TMIU to compare the specific radioactivities of the B apoprotein by both methods. That this new method described above led to the isolation of B apoprotein apparently free of soluble apoprotein was established as follows. First, the presence of soluble proteins in the insoluble pellet was checked by electrophoresis on polyacrylamide gels (21) , which showed only the presence of B apoprotein. Second, the amino acid composition of the NH4HCO3-insoluble protein of VLDL was compared vith the insoluble protein of LDL and the protein in the first half of the first peak obtained by gel filtration (Sephadex G-200 superfine, Pharmacia Fine Chemicals Inc., Piscataway, N. J.) of apoprotein which contains only B apoprotein. Amino acid analyses were performed by the method of Spackman et al. (24) on a Beckman 120B amino acid analyzer. The amino acid compositions of the NH4HCO3-insoluble apoprotein of Sf 20-400, 12-20, and 0-12 lipoproteins were found to be virtually identical (22) and similar to the B apoprotein data reported by others (23) . Third, the B apoprotein specific radioactivity of VLDL samples obtained during turnover studies was determined by both the TMU method and the procedure described above and found to be identical.
Determination of total plasma VLDL-B and LDL-B concentrations
Lipoproteins were isolated from duplicate 5-ml plasma samples of each subject. After removal of VLDL by ultracentrifugation, LDL were precipitated with heparin and MnCl2, as described by Burstein and Samaille (25) . Distribution of cholesterol and triglyceride among VLDL, LDL, and high density lipoproteins (supernate obtained after LDL precipitation) was determined using a Technicon AutoAnalyzer (Technicon Instruments Corp., Tarrytown, N. Y.) (Methods N24A and N78, respectively). The VLDL-B was isolated as described above (insolubility in 5 mM NH4HCO3); B apoprotein in VLDL and LDL were quantified by the Lowry procedure (18 to coniformii more closely to a two-pool than to a one-pool model in all studies except in subject 1, who ha(l a very low concentratioii of VLDL. The curves vere resolved visually by culrve-peeling.
The two-pool model proposed by Gurpide et al. (26) which describes the relationship between two pools, A and B, allows for independent entry and exit from 1)oth pools. As will be discussed later, the catabolismn ofVLDL-B may occulr in a variety of tissues, as well as in the generally accepted manner by conversion to LDL within the plasma; since it seemed likely that catabolism might occur in both pools, we selected a model that incorporated efflux of material from pool B as. well as from pool A. This does not imply that pool A is limited to the plasma and pool B to extravascular sites; in fact, pool A wvas found to extend beyond plasma. The flux of material through pool A, representing the influx of VLDL B apoprotein, is given by the equation:
where PRA = the flux through pool A (other than material recycled through pool B) and equals input into pool A or output from both pools; RA = dose of radioactivity reinjected into pool A; a and , f are the rate constants of the exponentials describing the biexponential specific radioactivity-time curve of VLDL-B (Fig. 1) ; and CA and CB are the specific radioactivities of VLDL apoprotein on the y axis which represent the intercepts of the two rate constants, a and ,. It is worth noting that this equation does not require knowledge of pool sizes. Fig. 2 .
Although loss of label might well occur in tissues that can degrade apoprotein B and that may make up part of pool B, it seems highly probable that input into the plasma occurs only from the liver and gut. The VLDL in plasma, liver, and gut are likely to belong to the rapidly turning over pool A, since nascent VLDL in those organs are the precursors of plasma VLDL. In two studies (subject 1, Sf 20-400; and subject 14, Sf 12-60) the pattern of removal of the lipoproteins appeared to be monoexponential until nearly 90% of the radioactivity had been removed from plasma. The turnover rate (k) was then calculated by the equation: Flux (mg/day) = Dose of injected radioactivity Area under specific activity-time curve (27) Ifall the labeled precursor (VLDL) is converted to the product (IDL), then the dose will be common to both and the flux through IDL can be calculated. If, however, only part of the precursor is metabolized to the product, then the flux of the latter will be overestimated.
This method was also used as a comparison for values obtained by two-pool analysis ofVLDL Sf 20-400 turnover, since the equations are similar. The agreement between the two methods of analysis averaged 95%. LDL turnover. This was calculated in two ways. The specific radioactivity-time curve of LDL-B was obtained whenever labeled VLDL-B was injected. Since most of these studies did not extend beyond 4 days, LDL turnover was calculated as follows. The specific radioactivity-time curves described by VLDL-B and LDL-B were plotted on arithmetic paper. The two curves intersected at various times between 18 and 36 h after injecting the labeled VLDL, generally at or FIGURE 2 Postulated two-pool model for VLDL metabolism. near the peak specific radioactivity of LDL. This is presumptive evidence for LDL being derived from VLDL, though it does not require that all VLDL is converted to LDL (27) . Recent data in man suggest that LDL-B is solely derived from VLDL-B (12) . Since this is believed to occur during the intravascular catabolism of VLDL, the area between the respective specific radioactivity-time curves should reflect the catabolic rate (k) of LDL. We have calculated this value of k for LDL in 12 subjects from the first 18 h of each experiment from the equation: k (per day) = Rate of rise in LDL specific radioactivity/Area between VLDL and LDL specific radioactivity curves (28) (the rate of rise was derived from the differences between the 18-and 2-h LDL specific radioactivities). The turnover of flux (in milligrams per day) was calculated by multiplying k by the intravascular pool of LDL-B.
In three subjects, the values for LDL turnover, as measured by the above technique, were compared with the more conventional two-pool analysis obtained over 14 days after the injection of labeled LDL. This was carried out by simultaneously injecting LDL labeled with 1251 and VLDL with 131I. The analysis was performed as described by others (29) . Agreement between the two methods was, for the three subjects, 82, 76, and 90%, lower values being obtained with the area between the specific activity-time curves method.
RESULTS
VLDL-B (Sf 20-400) turnover. This was carried out in 12 subjects, 7 of whom showed varying degrees of hypertriglyceridemia and hence increased amounts of Sf 20-400 lipoproteins (Tables I and IL) .
In every study, the specific radioactivity-time curve resolved visually by curve-peeling was multiexponential over at least 48 h (Fig. 1) . The first five points oIn the curve encompassing the first 12 h almost described a monoexponential function in most subjects; however, when the 48-h curve was resolved into two exponential functions by the curve-peeling technique, the first and faster exponential of the two-pool model conformed closely to a monoexponential function (Fig. 1) . However, in the normolipidemic subject (subject 1), in whom the concentration of VLDL-B was only 1.7 mg/ 100 ml, the specific activity-time curve appeared monoexponential until 95% of the radioactivity had left the Sf 20-400 fraction. In this single subject it seemed more appropriate to calculate the flux from a single-pool analysis and it was found to be 359 mg/day. VLDL-B flux was calculated with the two-pool model in the other 11 subjects and gave values between 637 and 3,060 mg/ day (Table II) .
The mass of pool A was also estimated by compartmental analysis and was found to be on average 30% larger than the intravascular content of VLDL-B (Table  II) .
In the subjects with normal or moderately raised levels of triglyceride, flux and pool size appeared to be related, suggesting that expansion of the pool was a function of increased input (Fig. 3) . The three subjects with the highest triglyceride levels showed an increase in pool size that was out of proportion to the increase in flux. On the other hand, one nornmolipidemic subject showed a disproportionately high flux of Sf 60-400 lipoproteins (subject 13).
VLDL-B kinetics in VLDL subfractions. The relationship between the metabolism of the Sf 20-400 anid the Sf 12-20 lipoprotein fractions was examined in the sttudies with labeled Sf 20-400. In seven of nine studies, the Sf 12-20 specific radioactivity curve intersected the Sf 20-400 curve before the specific radioactivity of the product had reached its peak (Fig. 4) 1, respectively) . However, in the three subjects with Type 4 lipoprotein phenotype (subjects 9, 10, and 11), the corresponding ratios were 1: 1.9, 1:3.1, and 1: 1.9. The areas under the Sf 12-20 curves were therefore greater than those under the Sf 20-400 curves, especially in the hypertriglyceridemic subjects; since flux is inversely related to the area under the curve, Sf 12-20 flux was clearly less than that of Sf 20-400 in subjects 9, 10, and 11. If some of the label injected with the Sf 20-400 lipoproteins was removed by a process other than through the Sf 12-20 fraction, then the estimated turnover of the latter fraction would be even less (as suggested by the direct measurement in subject 10). It therefore seems likely that in hypertriglyceridemic subjects a substantial fraction of VLDL-B catabolism may leave the circulation before being degraded to a lipoprotein of the Sf 12-20 size, and the possibility was considered that this may lie within the range Sf 12-60. It has recently been suggested on the basis of in vivo and in vitro studies that the appropriate density of the VLDL remnant might be in the range of Sf 20-60 (11, 30) . Accordingly, double-labeled experiments were carried out in two subjects, one with normal plasma lipids (subject 13) and one with moderately severe Type 4 hyperlipoproteinemia (subject 14). 60-400 specific radioactivity-time curves could be resolved into two exponentials. In subject 13 the Sf 12-60 curve could also be resolved into two exponentials, but in subject 14, the Sf 12-60 curve appeared monoexponential and flux was calculated accordingly. The flux of B apoprotein in the two lipoprotein fractions, measured from the two labels, were of a similar order (Table  III) , which, taken together with the precise precursorproduct characteristics of their respective specific radioactivity curves (determined from the Sf 60-400 labeling, Fig. 5 ), suggests that the major VLDL remnant has a density of around Sf 12-60. In a third subject (subject 15), only Sf 60-400 lipoproteins were injected and the flux of the Sf 12-60 fraction was calculated by the areas under the curves method: fluxes were again similar.
Conversion of VLDL to LDL. The specific radioactivity of the B apoprotein in LDL (d 1.019-1.063) was also measured in most subjects, primarily to define the nature of the VLDL to LDL relationship. In addition, the fractional rate of labelling of LDL protein was calculated from the rate of rise in LDL specific radioactivity and the rate of fall in VLDL specific radioactivity during the first 18 h. As described in Methods, this model requires that LDL-B is derived solely from the corresponding protein in VLDL. In all subjects, the LDL specific radioactivity curve intercepted the VLDL specific radioactivity curve at or very near to the peak specific radioactivity of LDL (Fig. 4) . This is consistent with VLDL-B being the source of LDL protein.
The calculation of LDL flux by this method was compared in three subjects (subjects 5, 6, and 8) with the 200.
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Thoo. This much more rapid estimate of LDL-B flUx was therefore compared in all subjects with the turnover of VLDL Sf 20-400 lipoproteins (Table IV) . The LDL flux varied from 5.5 to 18.7 mg/kg per day, which is in line with findings reported by others with the two-pool model (29) . There was little difference in LDL flux between the four subjects with hypertriglyceridemnia alone and the others. However, whereas LDL flux was substantially less than VLDL flux in at least three of the four purely hypertriglyceridemic subjects, the two measurements were much closer in the other subjects. This suggests that at higher concentrationis of VLDL a considerable fraction of VLDL-B turinover is catabolized by a route other than through LDL. In the one subject with severe xanthomatous hypercholesterolemia (subject 6), LDL flux was 12.8 mg/kg per day by this technique.
DISCUSSION
VLDL-B tuirnover. In nearly every study, the specific radioactivity-time curve during the first 48 h conformed to a two-pool model. Sigurdsson et al. (12) had also noted the curvilinear nature of the log-linear plot of the specific radioactivity-time curve, but coineluded that the initial 24-h segment was consistent with a monoexponential rate of removal. The data from some of our studies, and in particular in the normolipidemic subjects, could also be plotted visually in an apparently monoexponential manner but usually not beyond 12 h. By extending the duration of the studies, the multiexponential nature of VLDL catabolism was mIore clearly defined.
The two-pool characteristics of VLDL-B flux could have arisen artifactually if the specific radioactivity values were distorted by contaminating labeled proteins with turnover kinetics that differed from those of the B apoprotein. This possibility has been dealt with above. The absence of soluble proteins with polyacrylamide-gel electrophoresis of ammonium bicarbonate or TiMU-insoluble proteins, the similarity of the amino acid composition of the insoluble proteins derived from VLDL and LDL, and the similarity in the turnover rates derived from analysis of NH4HCO3 and TMIU-insoluble protein strongly suggest that contamination of the VLDL-B with other proteins was minimal (see Methods).
A two-pool model is consistent with some of the known metabolic characteristics of VLDL. First, more than one population of particles may be secreted into the plasma. It is known that carbohydrate-induced hypertriglyceridemia leads to the secretion of VLDL that are larger than those found in subjects eating normally (32) , and measurements of VLDL particle size show that hyperlipidemic subjects. may have a much higher proportion of large VLDL than do fasting normolipidemic individuals (23) .
However, it has not yet been shown that in any single individual VLDL particles of different size are secreted into the plasma at the one time.
The two-pool model might also reflect heterogeneity of catabolic processes. It is clear from experiments in which the protein or the lipid moieties of VLDL have been labeled that smaller species of lipoproteins are progressively formed as triglyceride and surface components of VLDL are removed (10, 11) . Barter and Nestel considered the possibility of independently metabolized pools of VLDL triglyceride that would lead to differing turnover rates for different subclasses of VLDL (33) . Instead, the findings suggested a stepwise transformation of larger to smaller lipoproteins with LDL representing the final step. However, the catabolic fLate of the B apoprotein moiety of VLDL may diverge from that of triglyceride during the formation of VLDL remnants which contain all the B apoprotein of the parent VLDL but very much less triglyceride (23, 34) . Experiments in the rat show that catabolism of VLDL-B may indeed proceed by more than one route (14) : Less than 10% of labeled B apoprotein in VLDL was reported to have been recovered in LDL, whereas the uptake of label in the liver was substantial (14) . The rate and extent of uptake of the B apoprotein in rat liver resembles that of the cholesteryl esters (35) which remain as the major core component of the partially catabolized VLDL. This provides strong evidence that at least in the rat, some remnant particles are removed by the liver while others are destined for conversion to LDL.
It is therefore possible that VLDL may not only be catabolized by more than one process, but that the turnover rate of protein through successive metabolic steps becomes altered. Eisenberg et al. (10) have reported a faster rate of transfer of labeled B apoprotein from VLDL to Sf 12-20 lipoproteins during the initial stages of heparin-induced VLDL catabolism than during the subsequent transfer of label to LDL. Such a heterogeneity of catabolic steps might be expected to lead to multicompartmental kinetics for VLDL-B turnover. The removal of VLDL-B in the rat also appears to be multiexponential (13) . This may reflect the very rapid rate of removal of VLDL apoprotein from the plasma coupled to the much slower rate of uptake and catabolism of remnants in the liver (14, 36) .
A third contributing factor to multiexponential kinetics might occur from the distribution of VLDL-B in more than one pool, with each pool having different turnover characteristics. While it is highly probable that the catabolism of VLDL takes place largely within the plasma, lipoproteins resembling VLDL have been identified in human lymph (37) . Catabolism of VLDL remnants has been described in several tissues (14, 36, 38) , and VLDL-B can be degraded in a variety of cultured cells2 (39) . The presence of VLDL-like par-ticles in the intestine (40) represents another possible pool of VLDL that might exchange with the intravascular pool.
The multiexponential nature of the specific activity curves might therefore reflect several factors: heterogeneity of turnover rates among several populations of VLDL particles, alternative catabolic processes, and catabolism within several tissue or lipoprotein pools.
VLDL remnant. The present findings, though limited, suggest that the major remnant of VLDL catabolism is in the Sf 12-60 range. This is based on the similar flux of B apoprotein through the Sf 60-400 and the Sf 12-60 lipoprotein fractions (subjects 13, 14, and 15) and the smaller flux of B apoprotein in the Sf 12-20 compared with the Sf 20-400 lipoproteins in the hypertriglyceridemic subjects (Table III) . This is consistent with two studies in the rat: Mj0s et al. have shown that the size of VLDL remnants is distributed mainly in the 300 to 400-A range (11) , and Eisenberg and Rachmilewitz have reported the remnant to have a mean Sf value of 30 and a diameter of 296 A (30) . In humans, VLDL-B is rapidly transferred from the Sf 100-400 to the Sf 20-60 fraction when heparin is injected (10) . On the other hand, with constant prolonged infusions of heparin, smaller lipoproteins in the Sf 12-20 range are also rapidly formed (41) , and in vitro NaCl-suppressible postheparin lipolytic activity can transform VLDL to LDL (22) .
Our findings suggest that most of VLDL may be degraded to Sf 20-60 lipoproteins but that in some subjects only a proportion of this is further catabolized to Sf 12-20, the remainder leaving the circulation without conversion to Sf 12-20 and then to Sf 0-12 lipoproteins. Compartmental studies reported by Hall et al. also suggest that the Sf 12-20 fraction, which had until recently been considered to be the major VLDL remnant, may be partly "bypassed" (42) . Conversion to LDL is clearly one fate of the VLDL remnant, and an estimate of this was obtained from our comparison ofVLDL-B turnover and LDL turnover.
LDL flux. The studies of Sigurdsson et al. suggest that in man LDL is solely derived from VLDL (12) . However, both in the monkey (43) and in the rat3 some LDL may be formed independently of VLDL catabolism and this may yet be demonstrated in man under certain circumstances.
The values obtained by the present technique were in reasonable agreement in three subjects with the turnover calculated from reinjected labeled LDL and were in the range reported for LDL turnover by others (29) . Of special interest was the similarity between VLDL B-and LDL-B flux (as well as Sf 12-20 B apoprotein) in the five subjects without hypertriglycerid-emia, suggesting total conversion of VLDL particles to LDL. However, as suggested by the data of Sigurdsson et al. (44) , alternate paths may be available for VLDL catabolism in hypertriglyceridemic subjects. In three of our four hypertriglyceridemic subjects, as little as onethird of VLDL-B flux appeared in LDL. Since the flux of LDL-B was similar in those with and without hypertriglyceridemia (Table IV) , whereas that of VLDL-B was much higher in the hypertriglyceridemic subjects, it is possible that LDL turnover cannot be readily increased to accommodate a higher flux of VLDL-B. A proportion of the latter is then catabolized elsewhere, possibly in the liver as occurs in the rat. Sigurdsson et al. have also reported normal values for LDL flux in hypertriglyceridemic subjects, many of whom presumilably showed increased VLDL turnover (45) .
The present studies in which the proteini of VLDL has been labeled also suggest that expansion of VLDL pools may be associated with increased input of VLDL-B. However, since several distinct metabolic processes contribute to the catabolism of VLDL, it is likely that turnover and pool size will not always coniform to the relationship shown in Fig. 3 .
The most relevant factor in the present conitext is the influence of overweight which is known to stinmulate VLDL secretion. It is therefore important to note that some of the hypertriglyceridemic subjects who showed increased VLDL-B turnover were also overweight.
